Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations
- 1 November 1983
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 2 (5), 865-871
- https://doi.org/10.1016/s0735-1097(83)80233-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Hemodynamic and hormonal responses during captopril therapy for heart failure: Acute, chronic and withdrawal studiesThe American Journal of Cardiology, 1982
- Long-term control of congestive heart failure with captoprilThe American Journal of Cardiology, 1982
- Synergistic antihypertensive effect of MK-421 and hydrochlorothiazideThe American Journal of Cardiology, 1982
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRILThe Lancet, 1979
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978